24 | Search Results | Clinical Gate

Professional development, competence and education

Published on 10/12/2016 by admin

Filed under Nursing & Midwifery & Medical Assistant

Last modified 10/12/2016

This article have been viewed 2560 times

JSPN

Published on 03/05/2016 by admin

Filed under Nephrology

Last modified 03/05/2016

This article have been viewed 3561 times

Japanese Clinical Practice Guidelines for IgA Nephropathy: Difference from KDIGO Guidelines

Published on 02/05/2016 by admin

Filed under Nephrology

Last modified 03/05/2016

This article have been viewed 6121 times

Podocyte Injury and Significance of Urinary Podocalyxin and Megalin

Published on 02/05/2016 by admin

Filed under Nephrology

Last modified 03/05/2016

This article have been viewed 4240 times

Is Tonsillectomy a Possible Treatment for IgA Nephropathy from Randomized Controlled Trial (RCT)?

Published on 02/05/2016 by admin

Filed under Nephrology

Last modified 03/05/2016

This article have been viewed 4508 times

How Different Are the Current Understandings of Treatments for IgA Nephropathy?

Published on 02/05/2016 by admin

Filed under Nephrology

Last modified 03/05/2016

This article have been viewed 4336 times

The Implication of the KDIGO Clinical Practice Guidelines on Management of IgA Nephropathy

Published on 02/05/2016 by admin

Filed under Nephrology

Last modified 03/05/2016

This article have been viewed 3205 times

Cytokines as Active Factors in Focal Segmental Glomerulosclerosis

Published on 02/05/2016 by admin

Filed under Nephrology

Last modified 03/05/2016

This article have been viewed 2112 times

Regulatory T Cells and Oxidative Stress in Minimal Change Nephropathy

Published on 02/05/2016 by admin

Filed under Nephrology

Last modified 03/05/2016

This article have been viewed 2986 times

Energy and Mammalian Target of Rapamycin Complex 1 (mTORC1) in Minimal Change Nephrotic Syndrome

Published on 02/05/2016 by admin

Filed under Nephrology

Last modified 03/05/2016

This article have been viewed 2101 times

Prognostic Indicators and Treatment of IgA Nephropathy in China

Published on 01/05/2016 by admin

Filed under Nephrology

Last modified 03/05/2016

This article have been viewed 4264 times

Complement Activation

Published on 01/05/2016 by admin

Filed under Nephrology

Last modified 03/05/2016

This article have been viewed 4291 times

IgA Nephropathy from the VALIGA European Study: Differences in Treatment Approaches Within Europe

Published on 01/05/2016 by admin

Filed under Nephrology

Last modified 03/05/2016

This article have been viewed 1962 times

The Differences in Etiology and Treatment of IgA Nephropathy in Korea

Published on 01/05/2016 by admin

Filed under Nephrology

Last modified 03/05/2016

This article have been viewed 2830 times

Is IgA Nephropathy a Single Disease?

Published on 01/05/2016 by admin

Filed under Nephrology

Last modified 03/05/2016

This article have been viewed 2828 times

Search Engine

Search Results: 24

Professional development, competence and education

JSPN

Japanese Clinical Practice Guidelines for IgA Nephropathy: Difference from KDIGO Guidelines

Podocyte Injury and Significance of Urinary Podocalyxin and Megalin

Is Tonsillectomy a Possible Treatment for IgA Nephropathy from Randomized Controlled Trial (RCT)?

How Different Are the Current Understandings of Treatments for IgA Nephropathy?

The Implication of the KDIGO Clinical Practice Guidelines on Management of IgA Nephropathy

Cytokines as Active Factors in Focal Segmental Glomerulosclerosis

Regulatory T Cells and Oxidative Stress in Minimal Change Nephropathy

Energy and Mammalian Target of Rapamycin Complex 1 (mTORC1) in Minimal Change Nephrotic Syndrome

Prognostic Indicators and Treatment of IgA Nephropathy in China

Complement Activation

IgA Nephropathy from the VALIGA European Study: Differences in Treatment Approaches Within Europe

The Differences in Etiology and Treatment of IgA Nephropathy in Korea

Is IgA Nephropathy a Single Disease?

Recent Posts

Meta

Categories